Neuroone Medical Technologies (NMTC) Return on Capital Employed Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 252.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -110.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 49.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 658.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -231.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 200.00 |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn | 6,906.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,906.00 |
| Dec 31, 2025 | 6,482.00 |
| Sep 30, 2025 | 35,625.00 |
| Jun 30, 2025 | 26,203.00 |
| Mar 31, 2025 | 14,113.00 |
| Dec 31, 2024 | 8,760.00 |
| Sep 30, 2024 | -17,316.00 |
| Jun 30, 2024 | -13,805.00 |
| Mar 31, 2024 | -18,117.00 |
| Dec 31, 2023 | -15,228.00 |
| Sep 30, 2023 | -12,256.00 |
| Jun 30, 2023 | -12,144.00 |
| Mar 31, 2023 | -5,930.00 |
| Dec 31, 2022 | 375.00 |
| Sep 30, 2022 | 2,259.00 |
| Jun 30, 2022 | -1,780.00 |
| Mar 31, 2022 | -970.00 |
| Dec 31, 2021 | 330,604.00 |
| Sep 30, 2021 | 8,453.00 |
| Jun 30, 2021 | -19,614.00 |
| Mar 31, 2021 | -21,840.00 |
| Dec 31, 2020 | -352,253.00 |
| Sep 30, 2020 | -102,051.00 |
| Jun 30, 2020 | 241,873.00 |
| Mar 31, 2020 | -67,372.00 |
| Jun 30, 2019 | -242,706.00 |
| Mar 31, 2019 | 74,712.00 |
| Dec 31, 2017 | 1,354.00 |
| Jun 30, 2014 | 3,931.00 |
| Mar 31, 2014 | 71,527.00 |
| Dec 31, 2013 | 143.00 |
| Sep 30, 2013 | -262,843.00 |
| Jun 30, 2013 | 122,250.00 |
| Mar 31, 2013 | 46,830.00 |
| Dec 31, 2012 | 65,871.00 |
| Sep 30, 2012 | 208,014.00 |